» Articles » PMID: 35132912

The Mechanism of Triptolide in the Treatment of Connective Tissue Disease-related Interstitial Lung Disease Based on Network Pharmacology and Molecular Docking

Overview
Journal Ann Med
Publisher Informa Healthcare
Specialty General Medicine
Date 2022 Feb 8
PMID 35132912
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Interstitial lung disease (ILD) is associated with substantial morbidity and mortality, which is one of the key systematic manifestations of connective tissue disease (CTD). Tripterygium wilfordii, known as Leigongteng in Chinese, has been applied to treat connective tissue disease-related interstitial lung disease (CTD-ILD) for many years. Triptolide is a key effective component from Tripterygium wilfordii. But the molecular mechanism of Triptolide for treating CTD-ILD is not yet clear.

Methods: Gaining insight into the molecular mechanism of Triptolide intervention CTD-ILD, we used the method of network pharmacology. And then we conducted drug-target networks to analyse the potential protein targets between Triptolide and CTD-ILD. Finally, AutoDock Vina was selected for molecular docking.

Results: By analysing the interaction genes between Triptolide and CTD-ILD, 242 genes were obtained. The top 10 targets of the highest enrichment scores were STAT3, AKT1, MAPK1, IL6, TP53, MAPK3, RELA, TNF, JUN, JAK2. GO and KEGG enrichment analysis exhibited that multiple signalling pathways were involved. PI3K-Akt, multiple virus infections, cancer signalling, chemokine, and apoptosis signalling pathway are the main pathways for Triptolide intervention CTD-ILD. And it is related to various biological processes such as inflammation, infection, cell apoptosis, and cancer. Molecular docking shows Triptolide can bind with its target protein in a good bond by intermolecular force.

Conclusions: This study preliminarily reveals the internal molecular mechanism of Triptolide interfere with CTD-ILD through multiple targets, multiple access, validated through molecular docking.KEY MESSAGESTriptolide intervention CTD-ILD, which are related to various biological processes such as inflammation, infection, cell apoptosis, and cancer.PI3K-Akt, multiple virus infections, and apoptosis signalling pathway are the main pathways for Triptolide intervention CTD-ILD.Triptolide can bind with related target protein in a good bond by Intermolecular force, exhibiting a good docking activity.

Citing Articles

Silicosis: from pathogenesis to therapeutics.

Yang B, Liu X, Peng C, Meng X, Jia Q Front Pharmacol. 2025; 16:1516200.

PMID: 39944632 PMC: 11813918. DOI: 10.3389/fphar.2025.1516200.


Construction of Candida albicans pRB895-SAP2-SC5314 With SAP2 High Expression and Its Effects on Adhesion.

Xue L, Yang L, Zhao B, Feng W, Yang J, Ma Y J Clin Lab Anal. 2024; 39(2):e25144.

PMID: 39727206 PMC: 11776491. DOI: 10.1002/jcla.25144.


Exploring the mechanism of fibrates regulating HIF-1A in the treatment of ischemic stroke based on network pharmacology and molecular docking.

Yang F, Yang Z, Yan Y, Gu Y, Wang P, Wang M BMC Res Notes. 2024; 17(1):387.

PMID: 39726005 PMC: 11670374. DOI: 10.1186/s13104-024-07031-z.


Cimifugin improves intestinal barrier dysfunction by upregulating SIRT1 to regulate the NRF2/HO-1 signaling pathway.

Zhang H, Xiong Z, He Y, Su H, Jiao Y Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39302422 DOI: 10.1007/s00210-024-03433-9.


Agrimonolide Inhibits the Malignant Progression of Non-small Cell Lung Cancer and Induces Ferroptosis through the mTOR Signaling Pathway.

Zhang X, Cai W, Yan Y Anticancer Agents Med Chem. 2024; 24(18):1371-1381.

PMID: 39129291 DOI: 10.2174/0118715206305421240715042502.


References
1.
Huang J, Zhou L, Wu H, Pavlos N, Chim S, Liu Q . Triptolide inhibits osteoclast formation, bone resorption, RANKL-mediated NF-қB activation and titanium particle-induced osteolysis in a mouse model. Mol Cell Endocrinol. 2014; 399:346-53. DOI: 10.1016/j.mce.2014.10.016. View

2.
Todd N, Scheraga R, Galvin J, Iacono A, Britt E, Luzina I . Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis. J Inflamm Res. 2013; 6:63-70. PMC: 3617818. DOI: 10.2147/JIR.S40673. View

3.
Guo Y, Nie Q, MacLean A, Li Y, Lei J, Li S . Multiscale Modeling of Inflammation-Induced Tumorigenesis Reveals Competing Oncogenic and Oncoprotective Roles for Inflammation. Cancer Res. 2017; 77(22):6429-6441. DOI: 10.1158/0008-5472.CAN-17-1662. View

4.
Varshney P, Saini N . PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(5 Pt A):1795-1803. DOI: 10.1016/j.bbadis.2018.02.003. View

5.
Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View